drugset
drugset / Trial / NCT07814651

A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With Acromegaly

NCT07814651 ↗

Phase 2 Completed 78 enrolled CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

This trial is a phase II clinical trial to evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of octreotide long-acting injection in patients with acromegaly.

Timeline

Start
2024-04-16
Primary completion
2026-04-09
Completion
2026-04-23

Drugs

EvaluationDrugModalityDoseRoute
Subject SYHX2008 Unknown — Subcutaneous
Comparator Sandostatin LAR Unknown — Intramuscular

Indications

acromegaly